Anticoagulants (warfarin, apixaban, daily aspirin), systemic corticosteroids, and immunosuppressants warrant a conversation with your prescribing physician before starting
Published clinical trials report a favorable safety profile for GHK-Cu with low rates of mild observations including localized application site irritation (5%), transient skin redness (3%), and itching (2%)
No evidence supported effectiveness through the proposed subcutaneous route
Unlike glutathione, your body cannot make its own vitamin C
For example, PER1 gene activity, which is often reduced in tumor progression, has been examined as a possible pathway of interest
Activation of HIF-1 by metallothionein contributes to cardiac protection in the diabetic heart